BDBM50261051 3-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-2,3-dihydrobenzo[d]imidazole-1-carboxamide::CHEMBL494787

SMILES O=C(Nc1cccc2ccccc12)n1c2ccccc2n(CCN2CCOCC2)c1=O

InChI Key InChIKey=ISVXIBNOIJJZGK-UHFFFAOYSA-N

Data  1 KI  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50261051   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50261051(3-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-2,...)
Affinity DataKi:  8nMAssay Description:Displacement of [3H]CP-55940 from human CB2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50261051(3-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-2,...)
Affinity DataEC50:  8nMAssay Description:Agonist activity at human CB2 receptor assessed as inhibition of forskolin-stimulated cAMP productionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed